{
  "retracted": false,
  "timestamp": 1508803200000,
  "updates": [
    {
      "timestamp": 1585473496702,
      "identifier": {
        "doi": "10.1182/bloodadvances.2017012922"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1182/bloodadvances.2017009613"
  },
  "publisher": "American Society of Hematology",
  "title": "Field JJ, Majerus E, Gordeuk VR, et al. Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease. Blood Adv. 2017;1(20):1645-1649."
}
